Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christine Hicking
Effects of Postponing Treatment in the Second Year of Cladribine Administration: Clinical Trial Simulation Analysis of Absolute Lymphocyte Counts and Relapse Rate in Patients With Relapsing-Remitting Multiple Sclerosis
Clinical Pharmacokinetics
Pharmacology
Related publications
Health State Utilities in Patients With Relapsing Remitting Multiple Sclerosis Treated With Cladribine Tablets
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment of Remitting-Relapsing Multiple Sclerosis (MS) With Cladribine: Results of an Open Pilot Study at 18 Months
Journal of Neurology
Neurology
Cost-Effectiveness of Cladribine Tablets, Alemtuzumab and Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis With High Disease Activity in England
Journal of Medical Economics
Health Policy
Sub-Analysis of Geographical Variations in the 2-Year Observational COPTIMIZE Trial of Patients With Relapsing–remitting Multiple Sclerosis Converting to Glatiramer Acetate
BMC Neurology
Medicine
Neurology
Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis
Arquivos de Neuro-Psiquiatria
Biological Psychiatry
Neurology
Pnd62 - Cost-Effectiveness of Cladribine Tablets in the Treatment of Patients With Highly Active Relapsing Multiple Sclerosis in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis
Archives of Neurology
Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
Neurotherapeutics
Neurology
Pharmacology
PND14 Budgetary Impact of the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
